06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 16, 2024, 12:58 | Insight
Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X: "Encouraging to…
Jun 16, 2024, 12:44 | Insight
Mara Antonoff: Dr Heather Wakelee clarifies the role of chemotherapy in NSCLC
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, shared on…
Jun 16, 2024, 11:38 | Cancer Types
Chordoma in Adults: What patients should know about
Chordoma is a rare, slow-growing malignant tumor that arises from remnants of the notochord, a…
Jun 16, 2024, 11:17 | Blog
Empowering discussion about a shared organizational goal to advance equitable cancer care - Association of Cancer Care Centers
Association of Cancer Care Centers made the following post on LinkedIn: "In just 4 days,…
Jun 16, 2024, 11:10 | Blog
Let’s remember that HPV affects everyone regardless of gender - European Cancer Organisation
European Cancer Organisation shared on LinkedIn: "On International mens health week 2024, let’s remember that HPV…
Jun 16, 2024, 10:58 | Blog
Kinjal Shankar Majumdar: Applications for IDEA 2025 opens on 1st July 2024
Kinjal Shankar Majumdar, Visiting Fellow at Healthcare Global Enterprises Limited, shared on LinkedIn "Recently awarded with…
Jun 16, 2024, 10:46 | Blog
Mallinckrodt is partnering with admedicum
Lung Cancer Europe shared on X: “Mallinckrodt, a patient-focused pharmaceutical company, is partnering with admedicum, a…
Jun 16, 2024, 10:08 | Positive
Nermean Mostafa: Celebrating the launch of cancer early detection and management awareness campaign in Egypt
Nermean Mostafa, Head of Clinical Oncology Unit at Ain Shams University Specialized Hospitals, shared on…
Jun 16, 2024, 09:13 | Insight
Estela Rodriguez: Subcutaneous vs IV Amivantamab + Lazertinib in NSCLC
Estela Rodriguez shared on X/Twitter: "PALOMA3 Subq (SC) vs IV Amivantamab + Lazertinib, in Refractory EGFR+…
Jun 16, 2024, 09:04 | Blog
The final day of the annual EORTC course
EORTC (European Organisation for Research and Treatment of Cancer) shared on LinkedIn:       …
All: 2741 Posts: 1311 - 1320
Special Coverage